Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2022 Jan;25(1):7-20.
doi: 10.1111/1756-185X.14266. Epub 2021 Dec 20.

2021 Asia-Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout

Jose Paulo P Lorenzo  1 , Ma Hanna Monica Z Sollano  1 , Evelyn O Salido  2 , Julie Li-Yu  3 , Sandra A Tankeh-Torres  4 , Ida Ayu Ratih Wulansari Manuaba  5 , Md Mujibur Rahman  6 , Binoy J Paul  7 , Mo Yin Mok  8 , Monika De Silva  9 , Prasanta Padhan  10 , Ai Lee Lim  11 , Melvin Marcial  3 , Jennifer Jeanne Vicera  3 , Syed Atiqul Haq  12 , Sami Salman  13 , Chiranthi K Liyanage  14 , Helen I Keen  15   16 , Cheng Yew Kuang  17   18 , James Cheng-Chung Wei  19 , Rakhma Yanti Hellmi  20 , Charlie E Chan Jr  21 , Worawit Louthrenoo  22
Affiliations
Practice Guideline

2021 Asia-Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout

Jose Paulo P Lorenzo et al. Int J Rheum Dis. 2022 Jan.

Abstract

Background: Gout is the most prevalent inflammatory arthritis in the Asia-Pacific region and worldwide. This clinical practice guideline (CPG) aims to provide recommendations based on systematically obtained evidence and values and preferences tailored to the unique needs of patients with gout and hyperuricemia in Asia, Australasia, and the Middle East. The target users of these guidelines are general practitioners and specialists, including rheumatologists, in these regions.

Methods: Relevant clinical questions were formulated by the Steering Committee. Systematic reviews of evidence were done, and certainty of evidence was assessed using Grading of Recommendations Assessment, Development and Evaluation methodology. A multi-sectoral consensus panel formulated the final recommendations.

Results: The Asia-Pacific League of Associations for Rheumatology Task Force developed this CPG for treatment of gout with 3 overarching principles and 22 recommendation statements that covered the treatment of asymptomatic hyperuricemia (2 statements), treatment of acute gout (4 statements), prophylaxis against gout flare when initiating urate-lowering therapy (3 statements), urate-lowering therapy (3 statements), treatment of chronic tophaceous gout (2 statements), treatment of complicated gout and non-responders (2 statements), treatment of gout with moderate to severe renal impairment (1 statement), and non-pharmacologic interventions (5 statements).

Conclusion: Recommendations for clinically relevant scenarios in the management of gout were formulated to guide physicians in administering individualized care.

Keywords: acute gout; chronic tophaceous gout; clinical practice guidelines; gout; non-pharmacologic; prophylaxis; urate-lowering therapy.

PubMed Disclaimer

Comment in

References

REFERENCES

    1. Singh J, Gaffo A. Gout epidemiology and comorbidities. Semin Arthritis Rheum. 2020;50(3S):S11-S16.
    1. Kim J, Kwak S, Lee H, Kim S, Choe J, Park S. Prevalence and incidence of gout in Korea: data from the national health claims database 2007-2015. Rheumatol Int. 2017;37(9):1499-1506.
    1. Zhu Y, Pandya B, Choi H. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum. 2011;63(10):3136-3141.
    1. Wahedduddin S, Singh J, Culhane-Pera K, Gertner E. Gout in the Hmong in the United States. J Clin Rheumatol. 2010;16(6):262-266.
    1. Singh J, Reddy S, Kundukulam J. Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol. 2011;23(2):192-202.

Publication types

Substances

LinkOut - more resources